Johnson & Johnson (JNJ)

145.62
0.28 0.19
NYSE : Health Technology
Prev Close 145.34
Open 144.99
Day Low/High 144.73 / 146.24
52 Wk Low/High 118.62 / 148.32
Volume 6.97M
Avg Volume 6.36M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 389.69B
EPS 0.50
P/E Ratio 246.27
Div & Yield 3.60 (2.40%)

Latest News

Weekly Roundup

Markets had another volatile week as trade tensions crossed currents with a U.S. midterm election that was closer than many had predicted.

Reviewing Some Winners After the Election Results

We think defense stocks, among other sectors, can rally.

Eli Lilly's Elanco Offload Offers Acquisition Flexibility

Eli Lilly's Elanco Offload Offers Acquisition Flexibility

Eli Lilly's confirmation of acquisition action could make pharmaceuticals an attractive investment space.

Two Studies Measure Performance Of ACUVUE OASYS With Transitions Light Intelligent Technology Contact Lenses In Simulated Sunlight, Day And Night Driving Conditions

Two Studies Measure Performance Of ACUVUE OASYS With Transitions Light Intelligent Technology Contact Lenses In Simulated Sunlight, Day And Night Driving Conditions

- First-of-its-kind photochromic contact lens delivered improved visual function compared to transparent contact lenses in simulated sunlight

What Is the Dow Jones Industrial Average?

What Is the Dow Jones Industrial Average?

The Dow Jones Industrial Average is a price-weighted average of 30 large American publicly traded companies on the stock market.

Jim Cramer: The Stock Market's Machine Buyers

Jim Cramer: The Stock Market's Machine Buyers

These are simply programs where some ETFs and handcrafted baskets are overwhelming both sides of the market.

Weekly Roundup

Markets experienced more volatility this week.

There Is Still Some Skepticism Out There

After two big up days I would not be surprised to see a pullback of sorts.

Weekly Roundup

Markets were volatile again this week.

Court Issues Ruling In ZYTIGA® Patent Infringement Litigation

Court Issues Ruling In ZYTIGA® Patent Infringement Litigation

NEW BRUNSWICK, N.J.

Portfolio Review: Taking a Look at Each Name

In light of recent market volatility, we want club members to know our view on every stock we own.

Johnson & Johnson Becomes #11 Most Shorted Dow Stock, Replacing Pfizer

Johnson & Johnson Becomes #11 Most Shorted Dow Stock, Replacing Pfizer

The most recent short interest data has been released for the 10/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Brace for Impact: Cramer's 'Mad Money' Recap (Friday 10/12/18)

Brace for Impact: Cramer's 'Mad Money' Recap (Friday 10/12/18)

This earnings season could be full of surprises. Jim Cramer has your game plan for next week.

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

Panic is not an investment strategy, says Jim Cramer. But when everyone else is panicking, that's when you need to buy.

Netflix, IBM and UnitedHealth Group Among Companies Reporting Monday, Tuesday

Netflix, IBM and UnitedHealth Group Among Companies Reporting Monday, Tuesday

A look at some of the major companies in the S&P 500 slated to report financial results in the early part of next week.

Running Hot: Cramer's 'Mad Money' Recap (Friday 10/5/18)

Running Hot: Cramer's 'Mad Money' Recap (Friday 10/5/18)

Jim Cramer says it'll be hard for stocks to stabilize until the Fed's stance softens. He's got your game plan for next week.

Clorox, Sirius XM Radio, New Relic: 'Mad Money' Lightning Round

Clorox, Sirius XM Radio, New Relic: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Clorox, Sirius XM Radio, New Relic, AbbVie, ShotSpotter and more.

Camping World, American Electric Power: 'Mad Money' Lightning Round

Camping World, American Electric Power: 'Mad Money' Lightning Round

Jim Cramer takes a look at Camping World, American Electric Power, Avangrid, Dominion Energy, Thor Industries, Spectrum Pharmaceuticals and more.

How Much Tighter?: Cramer's 'Mad Money' Recap (Wednesday 10/3/18)

How Much Tighter?: Cramer's 'Mad Money' Recap (Wednesday 10/3/18)

Jim Cramer asks if the Fed is trying so hard to cool the economy that it could crush wage growth.

The Power of Personalization: Cramer's 'Mad Money' Recap (Thursday 9/27/18)

The Power of Personalization: Cramer's 'Mad Money' Recap (Thursday 9/27/18)

Jim Cramer says you need to understand the theme behind the market's action, but also you need to know the timing.

Ferrari, Paychex, First American: 'Mad Money' Lightning Round

Ferrari, Paychex, First American: 'Mad Money' Lightning Round

Jim Cramer weighs in on Ferrari, Paychex, First American, Verastem, Halliburton and more.

Worried About the Right Thing?: Cramer's 'Mad Money' Recap (Tuesday 8/14/18)

Worried About the Right Thing?: Cramer's 'Mad Money' Recap (Tuesday 8/14/18)

Jim Cramer says some people are worried about tariffs and Turkey, but he's more concerned about spending patterns at home.

JetBlue, Southwest, Johnson & Johnson: 'Mad Money' Lightning Round

JetBlue, Southwest, Johnson & Johnson: 'Mad Money' Lightning Round

Jim Cramer takes a look at JetBlue, Southwest, Johnson & Johnson, Aspen Technology, Stratasys, Laredo Petroleum, Lumber Liquidators, and more.

Your Game Plan For Earnings: Cramer's 'Mad Money' Recap (Friday 8/3/18)

Your Game Plan For Earnings: Cramer's 'Mad Money' Recap (Friday 8/3/18)

Jim Cramer has the game plan for next week, and he also talks about how to buy stocks that are right for you.

New Home Sales Disappoint

We believe the significant miss and decline in in average selling prices point to potential cracks in the U.S. economic expansion.

J&J Makes Offer to Buy Japanese Cosmetics Firm Ci:z

J&J Makes Offer to Buy Japanese Cosmetics Firm Ci:z

The U.S. healthcare company has owned 19.9% of Ci:z since July 2016.

Johnson & Johnson Announces Offer To Acquire Ci:z Holdings Co., Ltd.

Johnson & Johnson Announces Offer To Acquire Ci:z Holdings Co., Ltd.

Acquisition is Expected to Expand J&J's Consumer Portfolio of Science-based Dermocosmetic Beauty Products

TheStreet Quant Rating: B (Buy)